KeifeRx Appoints Garrett Vygantas, MD, MBA, to Board of Directors

WASHINGTON, Feb. 14, 2023 -- (Healthcare Sales & Marketing Network) -- KeifeRx, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for neurodegenerative and immune diseases, announce... Biopharmaceuticals, Neurology, Personnel KeifeRx, tyrosine kinase inhibitor, Alzheimer's, Lewy Body Dementia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news